Contravisory Investment Management Inc. cut its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 59.2% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,433 shares of the company’s stock after selling 2,081 shares during the quarter. Contravisory Investment Management Inc.’s holdings in Procter & Gamble were worth $248,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in PG. Wulff Hansen & CO. grew its holdings in shares of Procter & Gamble by 16,292.0% during the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after buying an additional 3,653,477 shares during the last quarter. TD Asset Management Inc boosted its stake in Procter & Gamble by 114.9% during the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares during the last quarter. AMF Tjanstepension AB increased its holdings in Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Swedbank AB bought a new position in shares of Procter & Gamble in the first quarter valued at approximately $233,788,000. Finally, Ilex Capital Partners UK LLP purchased a new position in shares of Procter & Gamble during the first quarter valued at approximately $228,212,000. 65.77% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have issued reports on PG shares. Evercore ISI lifted their price objective on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. TD Cowen started coverage on shares of Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Stifel Nicolaus increased their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Thursday, August 29th. Finally, Royal Bank of Canada upped their target price on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a report on Wednesday, July 31st. Ten research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $175.05.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the completion of the sale, the insider now directly owns 13,072 shares in the company, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the sale, the insider now owns 13,072 shares of the company’s stock, valued at $2,212,043.84. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.
Procter & Gamble Trading Up 1.3 %
Shares of PG opened at $171.09 on Friday. The Procter & Gamble Company has a twelve month low of $141.66 and a twelve month high of $177.94. The stock has a market cap of $403.80 billion, a PE ratio of 27.96, a P/E/G ratio of 3.67 and a beta of 0.41. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The business’s 50-day moving average price is $171.48 and its 200-day moving average price is $166.74.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the prior year, the firm posted $1.37 EPS. Procter & Gamble’s revenue was down .1% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.35%. Procter & Gamble’s dividend payout ratio is currently 65.69%.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Business Services Stocks Investing
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- What is a buyback in stocks? A comprehensive guide for investors
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- What Are the FAANG Stocks and Are They Good Investments?
- 4 Quirky ETFs With Big Potential for Impressive Gains
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.